Immunotherapy in Non-Small Cell Lung Cancer: Shifting Prognostic Paradigms.

Barnet, Megan B; Cooper, Wendy A; Boyer, Michael J; Kao, Steven

Barnet, Megan B; Cooper, Wendy A; Boyer, Michael J; Kao, Steven.

Afiliação

Barnet MB; The Garvan Institute of Medical Research, Darlinghurst, NSW 2010, Australia. m.barnet@garvan.org.au.
Cooper WA; Graduate Research School, University of New South Wales, Sydney, NSW 2052, Australia. m.barnet@garvan.org.au.
Boyer MJ; Sydney Medical School, The University of Sydney, Camperdown, NSW 2006, Australia. m.barnet@garvan.org.au.
Kao S; Sydney Medical School, The University of Sydney, Camperdown, NSW 2006, Australia. wendy.cooper@health.nsw.gov.au.

J Clin Med ; 7(6)2018 Jun 14.

Article em En | MEDLINE | ID: mdl-29904031

Palavras-chave

checkpoint inhibitors; immunotherapy; non-small cell lung cancer

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: J Clin Med Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Austrália

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google